| Institution: | 1. Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège, Belgium;2. Division of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines, Liège University, B-4000 Liège, Belgium;1. Hulunbuir Clinical Medical College, Inner Mongolia University for Nationalities, Hailar District, Hulunbuir City, Inner Mongolia Autonomous Region, China;2. Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China;1. Department of Gastroenterology, Hepatology, and Nutrition, University of Texas MD Anderson Cancer Center, Houston, Texas;2. Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas;3. Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota;4. Department of Internal Medicine/Gastroenterology, Mayo Clinic College of Medicine, Rochester, Minnesota;5. Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts;1. Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece;2. Department of Diabetes and Endocrinology, Epsom & St Helier University Hospitals, Surrey SM5 1AA, UK;3. Unit for Metabolic Medicine, Cardiovascular Division, Faculty of Life Sciences & Medicine, King''s College, London WC2R 2LS, UK |
